生物技术进展 ›› 2012, Vol. 2 ›› Issue (4): 297-303.DOI: 10.3969/j.issn.2095-2341.2012.04.11
• 国际追踪 • 上一篇
Andrea Yankelevich, David Mergen*
出版日期:
发布日期:
Andrea Yankelevich, David Mergen
Online:
Published:
摘要: 阿根廷仍然是继美国和巴西之后第三大生物技术作物生产国,产量占到全球生物技术作物产量的15%。2011年5月19日,阿根廷政府批准先正达公司研发的转基因玉米MIR162可以进行生产和商业化,该产品在欧洲尚未获批,这一举措代表着阿根廷向着欧盟的“镜子政策”的反方向迈出了一步。为了找到一种承认知识产权的机制,孟山都公司制订了(在种子行业的支持下)与农民签署的私人协议。到目前为止,3 640个农民签署了协议,占到种植总面积的31.5%.
关键词: 阿根廷, 农业生物技术, 贸易与生产, 政策
Abstract: Argentina continues to be the third largest producer of biotech crops after the United States and Brazil, producing 15 percent of the world s biotech production. On May 19, 2011, the government approved Syngenta s corn event MIR162 for production and commercialization and as the event is not yet approved in Europe, this represents a step forward against the “mirror policy” with the European Union. In an effort to move forward in finding a mechanism to recognize intellectual property rights, Monsanto (with support of the seed industry) developed a private agreement with farmers. Up until now, 3 640 farmers have signed the agreement, which represents 31.5 percent of the total area.
Key words: Argentina, agricultural biotechnology, trade and production, policy
Andrea Yankelevich, David Mergen. 阿根廷农业生物技术年报(2011)[J]. 生物技术进展, 2012, 2(4): 297-303.
Andrea Yankelevich, David Mergen*. Argentina Agricultural Biotechnology Annual (2011)[J]. journal1, 2012, 2(4): 297-303.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.swjsjz.cn/CN/10.3969/j.issn.2095-2341.2012.04.11
https://www.swjsjz.cn/CN/Y2012/V2/I4/297